UK markets close in 3 hours 17 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
171.81-2.46 (-1.41%)
At close: 04:00PM EDT
172.55 +0.74 (+0.43%)
Pre-market: 08:13AM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • T
    Titos
    The weak earnings and future guidance from Novavax today reaffirm to us that in the real world, the average Joe and Jane are either folks who are okay with vaccines (or pro) or folks who are anti-hesitant. Folks who are okay with vaccines tend to just get the one most strongly recommended by the CDC. Those who are trying to make it about protein vaccines are really just a very small few, mostly made up of investors in the company.
  • p
    paul
    What’s the bad news after hours?
  • T
    Titos
    Novavax yesterday: Vaccine demand is weakening. Moderna today: Hold my syringe. "Moderna And the European Commission (EC) Amend Covid-19 Vaccine Agreement to Supply Omicron-Containing Bivalent Candidates; EC Purchases Additional 15 million Doses."
  • M
    Miguel
    EC adds 15M MRNA doses, and amends delivery schedule. "Scheduled doses in Jul and Aug of MRNA's vax are deferred to later in 2022, and remaining doses converted to Omicron-containing bivalent vaccines, pending approval by the European Medicines Agency (EMA)."
    Now it's wait and see what USG decides for fall rollout.
  • T
    Terminal Gravity
    Great CPI report. Next leg up to higher highs. For those that shorted in the $190s, well done but it's time to book your profits. Expecting big news over the coming weeks as we head into the fall/winter.
  • t
    tarik - original
    https://www.thediff.co/p/modernas-bets-moonshots-and-platforms?s=r&utm_campaign=post&utm_medium=web&utm_source=direct
  • J
    Jose
    Further to an earlier question - The P/E of Moderna is very low because of future revenue uncertainty. If it was reasonable that they could maintain the current revenues for the foreseeable future, the P/E would certainly be in the range of 3x current P/E.

    Regards,
  • M
    Miguel
    @Ozone. Who is tanking??? Right now NVAX -30%. BNTX and MRNA -5% each.
    NVAX multiple -25% days in past year. Last week when I said NVAX has such a poor performance record it had no where to go but up. I was wrong, this last ER cut deep into EOY. Now 5 trailing quarters missed, -6$ eps, and cut annual projections in half.
    That's not just NVAX management, which is horrible at best, that indicates much much deeper problems.
    Thanks for your concern with BNTX and MRNA, we'll be fine. Worry about NVAX, they're really in bad shape...
    GL LONGS.
  • D
    DonSanPablo
    Moderna pursuing to spend its Covid-19 cash on its own pipeline and stock buybacks in my view make them undervalue today. With the potential of Moderna making news on a solution to cancer treatment, their share price as I've commented previously will increase exponentially over time.
  • K
    KEVIN ARTHUR
    Europe orders more moderna - key to staying open
  • S
    StockWiz
    The manipulators are hard at work trying to depress the share price while the Dow and Nasd rally. Perhaps a good time for the stock buyback to kick-in.
  • j
    joe
    Positive news with EU and stock drops $10
  • B
    Ben
    Novavax is not doing well! Is it possible that MRNA is taking their share. If so, MRNA should be up not down.
  • T
    Titos
    Tomorrow on YF, premiering at 10 am eastern: "Moderna CEO discusses about covid-19 risks, vaccine boosters, mrna technology, and more." GLTA longs.
  • j
    joe
    Down $5 AH why?
  • t
    tarik - original
    The rerate of big pharma is here which has probably been a prerequisite for our stock price to release. To properly value Moderna is to acknowledge old pharma has no future as their drugs come off patents. Gene editing & mRNA will produce 90% of the worlds medicine hence forth.
  • B
    BearTrap
    MRNA is now taking orders for pies for shorts, but hurry, they won't last long!!!!
  • Y
    Ykp
    Just hold ! This is just the way big sharks want your shares before mRNA heads back up! Just like previous $120’s-150’s many times before heading up to 190’s.
    Stay long!
  • B
    Benjo
    MRNA is not NVAX. I am repeating $272 on this.
    Just don't come before running train !!
  • S
    Sell The News
    $NVAX conversation
    $JNJ $MRNA $BNTX ANNOUNCES CLOSURE ON COVlD VAX MANUFACTURING PLANT AFTER NO FUTURE ORDERS
    https://www.reuters.com/business/healthcare-pharmaceuticals/safricas-aspen-covid-19-vaccine-plant-risks-closure-after-no-orders-executive-2022-05-01/